GlaxoSmithKline Recalls Mupirocin Calcium Cream Due to Penicillin Contamination
GlaxoSmithKline is recalling Mupirocin Calcium Cream, 2%, because the product was contaminated with penicillin and foreign substances during manufacturing.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, especially given the risk of anaphylaxis from penicillin contamination in a drug product.
Plain-English summary
GlaxoSmithKline, LLC. is recalling Mupirocin Calcium Cream, 2%, in 15g and 30g tubes. The recall involves specific lots of the prescription medication manufactured by Glaxo Operations UK Ltd. for GlaxoSmithKline.
The recall was initiated because the product was contaminated with penicillin and foreign substances during the manufacturing process. This contamination poses a risk to patients, particularly those with penicillin allergies.
The affected product was distributed nationwide and in Puerto Rico. Consumers and healthcare providers should stop using the recalled product and return it to the pharmacy or contact GlaxoSmithKline for instructions on disposal or replacement.
The recalled product
- Product
- Mupirocin Calcium Cream, 2%, a) 15g tube (NDC 66993-942-15),b) 30g tube (NDC 66993-942-31), Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, UK for GlaxoSmithKline PO Box 1217 Zebulon, NC 27597-1217.
- Manufacturer
- GlaxoSmithKline, LLC.
- Category
- Drug — Topical Antibiotic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: C690076
- C693373
- Exp 2/2016
- Lot #: C701378
- C701376
- Exp 4/2016
- Lot #: C704164
- Exp 5/2016
- Lot #: C713687
- Exp 8/2016
- Lot #: C719467
- C718203
- Exp 9/2016
- Lot #: C723641
- Exp 10/2016
- Lot #: C683884
- Exp 12/2016
- Lot #: C697653
- Exp 3/2016
- Lot #: C710477
Distribution
Part of a larger recall action
This product is one of 4 recalled by GlaxoSmithKline, LLC. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · GlaxoSmithKline, LLC.
See all →- ModerateTIVICAY HIV medication carton mislabeled with incorrect expiration date
FDA (Drugs) · 2024-06-12
- ModerateAnoro Ellipta inhalation powder recalled for failed release testing defect
FDA (Drugs) · 2024-01-03
- ModerateDrug Recall: Tivicay Tablets with Incorrect Expiration Date on Label
FDA (Drugs) · 2022-06-01
- HighGlaxoSmithKline Recalls Ventolin HFA Inhalers Due to Defective Delivery System
FDA (Drugs) · 2017-05-31
- ModerateGlaxoSmithKline Recalls Ventolin Inhalers Due to Defective Delivery System
FDA (Drugs) · 2017-04-12
Same hazard · penicillin contamination
See all →- SevereGlaxoSmithKline Recalls Bactroban Nasal Ointment Due to Penicillin Contamination
FDA (Drugs) · 2016-07-27
- SevereGlaxoSmithKline Recalls Bactroban Cream Due to Penicillin Cross Contamination
FDA (Drugs) · 2016-07-27
- SevereGlaxoSmithKline Recalls Bactroban Cream Due to Penicillin Cross Contamination
FDA (Drugs) · 2016-07-27
- SevereLife Science Pharmacy Recalls Compounded Estriol Creams Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls HCG Injections Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09